This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1983;14(2):295-335.

doi: 10.3109/03602538308991392.

Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults

PMID: 6341027
DOI: 10.3109/03602538308991392

Review

Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults

T J Haley. Drug Metab Rev. 1983.

. 1983;14(2):295-335.

doi: 10.3109/03602538308991392.

Author

PMID: 6341027
DOI: 10.3109/03602538308991392

No abstract available

PubMed Disclaimer

Similar articles

Pharmacokinetics of theophylline in neonates.
Simons FE, Rigatto H, Simons KJ. Simons FE, et al. Semin Perinatol. 1981 Oct;5(4):337-45. Semin Perinatol. 1981. PMID: 7302609
Methylxanthines in apnea of prematurity.
Aranda JV, Turmen T. Aranda JV, et al. Clin Perinatol. 1979 Mar;6(1):87-108. Clin Perinatol. 1979. PMID: 383366 Review.
Factors affecting theophylline pharmacokinetics in premature infants with apnea.
Hilligoss DM, Jusko WJ, Koup JR, Giacoia G. Hilligoss DM, et al. Dev Pharmacol Ther. 1980;1(1):6-15. Dev Pharmacol Ther. 1980. PMID: 7438966
Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant.
Boutroy MJ, Vert P, Royer RJ, Monin P, Royer-Morrot MJ. Boutroy MJ, et al. J Pediatr. 1979 Jun;94(6):996-8. doi: 10.1016/s0022-3476(79)80248-6. J Pediatr. 1979. PMID: 448556 No abstract available.
Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.
Ginsberg G, Hattis D, Russ A, Sonawane B. Ginsberg G, et al. J Toxicol Environ Health A. 2004 Feb 27;67(4):297-329. doi: 10.1080/15287390490273550. J Toxicol Environ Health A. 2004. PMID: 14713563 Review.

See all similar articles

Cited by

Clinical pharmacokinetics of vasodilators. Part II.
Kirsten R, Nelson K, Kirsten D, Heintz B. Kirsten R, et al. Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002. Clin Pharmacokinet. 1998. PMID: 9673832 Review.
The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response.
Sutrisna E. Sutrisna E. J Clin Diagn Res. 2016 Nov;10(11):FE01-FE03. doi: 10.7860/JCDR/2016/21067.8914. Epub 2016 Nov 1. J Clin Diagn Res. 2016. PMID: 28050398 Free PMC article. Review.
Bioluminescent Antibodies for Point-of-Care Diagnostics.
Xue L, Yu Q, Griss R, Schena A, Johnsson K. Xue L, et al. Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7112-7116. doi: 10.1002/anie.201702403. Epub 2017 May 16. Angew Chem Int Ed Engl. 2017. PMID: 28510347 Free PMC article.
Anti-allergy and anti-asthma drugs. Disposition in infancy and childhood.
Sweeney GD, MacLeod SM. Sweeney GD, et al. Clin Pharmacokinet. 1989;17 Suppl 1:156-68. doi: 10.2165/00003088-198900171-00011. Clin Pharmacokinet. 1989. PMID: 2692938 Review.
Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism.
Winstanley PA, Tjia J, Back DJ, Hobson D, Breckenridge AM. Winstanley PA, et al. Br J Clin Pharmacol. 1985 Jul;20(1):47-53. doi: 10.1111/j.1365-2125.1985.tb02797.x. Br J Clin Pharmacol. 1985. PMID: 4027135 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- Pharmacogenomics Knowledge Base